Cai Xiong, Xiong Jun, Hu Qing-Gang, Zhao Qiu-Dong, Wu Dong, Tang Li-Gong, Wan Chi-Dan, Wei Li-Xin
Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Tumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, 200438, China.
J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):873-879. doi: 10.1007/s11596-017-1820-y. Epub 2017 Dec 21.
Combined hepatocellular-cholangiocarcinoma (CHC) is a mixed tumor containing elements of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). Its remarkable histological heterogeneity has been linked to putative hepatic progenitor cell (HPC) origin. However, detailed histological or phenotypic description is rarely documented. In the present study, we reassessed 68 cases previously diagnosed as hepatitis B-related CHCs by immunohistochemistry and double-fluorescence immunostaining, focusing on HPC associated phenotypic observation of intermediate area of the tumor. It was found that tumor cells showed remarkable heterogeneity in intermediate area. Tumor cells with intermediate morphology between hepatocytes and cholangiocytes were oval-shaped and small with scant cytoplasm and hyperchromatic nuclei, arranging in solid nests mostly. By Keratin 7 (K7) staining, it appeared that the nests of tumor cells represented a maturation process from the undifferentiated small cells to mature hepatocytes through the "transitional" cells. Then, these small cells were further confirmed with intermediate phenotype as HPC by exploring immature hepatocellular marker and HPC/biliary markers co-localization. In conclusion, the HPC associated trait in CHC can be interpreted by HPC origin or gain of "stemness" by dedifferentiation. It is still too soon to give a final word that it is innate or acquired signature of HPC associated trait in CHC.
肝细胞-胆管癌(CHC)是一种混合性肿瘤,包含肝细胞癌(HCC)和胆管癌(CC)的成分。其显著的组织学异质性与假定的肝祖细胞(HPC)起源有关。然而,详细的组织学或表型描述鲜有记录。在本研究中,我们通过免疫组织化学和双荧光免疫染色对68例先前诊断为乙型肝炎相关CHC的病例进行了重新评估,重点关注肿瘤中间区域与HPC相关的表型观察。结果发现,肿瘤细胞在中间区域表现出显著的异质性。具有介于肝细胞和胆管细胞之间中间形态的肿瘤细胞呈椭圆形且小,胞质稀少,核深染,大多排列成实性巢状。通过角蛋白7(K7)染色,肿瘤细胞巢似乎呈现出一个从未分化的小细胞通过“过渡”细胞向成熟肝细胞的成熟过程。然后,通过探索未成熟肝细胞标志物以及HPC/胆管标志物的共定位,进一步证实这些小细胞具有作为HPC的中间表型。总之,CHC中与HPC相关的特征可以通过HPC起源或去分化获得“干性”来解释。现在就断定它是CHC中HPC相关特征的固有或后天特征还为时过早。